Vanguard Information Technology Index Fu (VGT)
$303.19 4.98 (1.62%)
20:00 EDT VGT Stock Quote Delayed 30 Minutes
Previous Close $303.19
Market Cap 32.31B
PE Ratio -
Volume (Avg. Vol.) 1.02M
Day's Range 300.70 - 307.14
52-Week Range 179.45 - 308.47
Dividend & Yield 1.95 (0.64%)
VGT Stock Predictions, Articles, and Vanguard Information Technology Index Fu News
- From InvestorPlace
- From the Web
While tech stocks can provide hefty returns, they are also quite risky. However, that's why investing in tech ETFs is a better approach.
There's nothing "artificial" about these AI stocks to buy now. Each represents cutting-edge technology, and offers solid income along the way.
While these ETFs might have been among the best ETFs to buy over the past five years, the long-term cases for some aren't guaranteed.
Sometimes you may need or want a portfolio that can earn you money without a lot of babysitting. Here are 9 ETFs to help you do just that.
The market has been continuing its upward haul after the stumble in the fourth quarter of 2018. Here are some stocks to buy going forward.
These are among the best ETFs for both growth and income. Here's what investors need to know about each ETF.
Many high-profile stocks and ETFs will be impacted by GICS reshuffling. Here is what investors need to know. Compare Brokers....
Investors seeking to tap the bullishness in the tech titan could consider the following ETFs. These funds have Apple as their top firm with a double-digit alloc....
If you're looking for ways to make your portfolio more low-maintenance as you take in the summer sun, these low-stress ETFs are well worth a look.
These sector ETFs have a Zacks Rank #1 or 2 and are likely to outperform ahead. Compare Brokers....
Google parent company Alphabet reports impressive Q3 results.
Microsoft delighted investors with stellar fiscal first-quarter 2018 results on strong performance in its fast-growing cloud business.
Apple shares fall based on an analyst report which indicates that the demand for iPhone 8 is a lot lower than that for previous models; technical issues in Appl...
The new iPhone X will feature a stunning new design and plenty of extras, which will give it a major upgrade over its predecessors.
From Analyst Ratings
Cowen & Co. analyst Ritu Baral reiterated an Outperform rating on Milestone Pharmaceuticals (NASDAQ: MIST) yesterday and set a price target of $12.00. The company’s shares closed last Friday at $8.44. The word on The Street in general, suggests a Moderate Buy analyst consensus rating for Milestone Pharmaceuticals with a $15.00 average price target, representing
From Seeking Alpha